By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Novo Nordisk A/S 

Novo Allé

Bagsvaerd    2880  Denmark
Phone: 45-4444-8888 Fax: 45-4449-0555


Big Pharma


CelTor Biosystems, Inc.  Research collaboration

Aradigm Corporation  Commercial agreement to develop AERx technology for the delivery of insulin, insulin analogues and other glucose-lowering agents for diabetes management.


Maxygen, Inc. 

Intergen Company 

Company News
Novo Nordisk A/S (NVO) Release: Emerging Data Could Begin To Redefine How Cities Address The Growing Diabetes Epidemic 11/10/2015 10:52:49 AM
Great Place To Work And Fortune Name Novo Nordisk A/S (NVO) As One Of The 50 Best Workplaces For Diversity In US 11/10/2015 10:21:40 AM
Novo Nordisk A/S (NVO) Release: Data Presented At ObesityWeek Showed Saxenda (liraglutide [rDNA origin] injection) Treatment Demonstrated Significant And Sustained Weight Loss Over Three Years Compared With Placebo 11/4/2015 11:51:08 AM
Emisphere (EMIS), Novo Nordisk A/S (NVO) Ink $221 Million+ Deal Develop Oral Formulations of Four Molecules Targeting Metabolic Indications 10/15/2015 6:52:41 AM
Novo Nordisk A/S (NVO)'s Sørensen Named Best-Performing CEO in the World 10/13/2015 6:46:37 AM
Xybion Announces That Novo Nordisk A/S (NVO) Selects Pristima To Manage Pharmacology Research Studies Across All Research Sites 10/1/2015 11:03:45 AM
Novo Nordisk A/S (NVO) Launches New Medical Resource For People Living With Hemophilia And Other Rare Bleeding Disorders 9/29/2015 10:48:57 AM
Novo Nordisk A/S (NVO) Finally Bags Diabetes Drug Tresiba U.S. Approval 9/28/2015 6:07:56 AM
Novo Nordisk A/S (NVO) New Plant In Iran – How Will The Local Production Of Insulin Impact The Pharma Market? 9/24/2015 10:08:38 AM
Novo Nordisk A/S (NVO) to Build $78 Million Plant in Iran 9/22/2015 6:32:28 AM